BRAEMAR HOTELS & RESORTS INC (BHR)

US10482B1017 - REIT

3.26  +0.02 (+0.62%)

After market: 3.26 0 (0%)

Fundamental Rating

2

BHR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 130 industry peers in the Diversified REITs industry. BHR has a bad profitability rating. Also its financial health evaluation is rather negative. BHR is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

BHR had negative earnings in the past year.
BHR had a positive operating cash flow in the past year.
In the past 5 years BHR always reported negative net income.
BHR had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -2.34%, BHR is not doing good in the industry: 81.25% of the companies in the same industry are doing better.
BHR has a Return On Equity of -6.91%. This is in the lower half of the industry: BHR underperforms 78.13% of its industry peers.
BHR has a worse Return On Invested Capital (1.77%) than 74.22% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BHR is in line with the industry average of 3.08%.
The last Return On Invested Capital (1.77%) for BHR is above the 3 year average (1.72%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -2.34%
ROE -6.91%
ROIC 1.77%
ROA(3y)-1.97%
ROA(5y)-2.68%
ROE(3y)-6.19%
ROE(5y)-10.17%
ROIC(3y)1.72%
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 5.81%, BHR is doing worse than 86.72% of the companies in the same industry.
BHR's Operating Margin has declined in the last couple of years.
The Gross Margin of BHR (69.13%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of BHR has remained more or less at the same level.
Industry RankSector Rank
OM 5.81%
PM (TTM) N/A
GM 69.13%
OM growth 3YN/A
OM growth 5Y-6.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5Y-0.43%

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BHR is destroying value.
Compared to 1 year ago, BHR has less shares outstanding
Compared to 5 years ago, BHR has more shares outstanding
BHR has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.22, we must say that BHR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.22, BHR is not doing good in the industry: 71.88% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.64 is on the high side and indicates that BHR has dependencies on debt financing.
BHR has a Debt to Equity ratio of 1.64. This is in the lower half of the industry: BHR underperforms 67.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF N/A
Altman-Z 0.22
ROIC/WACC0.23
WACC7.56%

2.3 Liquidity

A Current Ratio of 1.17 indicates that BHR should not have too much problems paying its short term obligations.
With a Current ratio value of 1.17, BHR perfoms like the industry average, outperforming 47.66% of the companies in the same industry.
A Quick Ratio of 1.15 indicates that BHR should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.15, BHR is in line with its industry, outperforming 49.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.15

2

3. Growth

3.1 Past

BHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.50%, which is quite good.
The Revenue has decreased by -0.11% in the past year.
Measured over the past years, BHR shows a quite strong growth in Revenue. The Revenue has been growing by 11.38% on average per year.
EPS 1Y (TTM)12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96%
Revenue 1Y (TTM)-0.11%
Revenue growth 3Y48.23%
Revenue growth 5Y11.38%
Sales Q2Q%-7.14%

3.2 Future

Based on estimates for the next years, BHR will show a very negative growth in Earnings Per Share. The EPS will decrease by -16.17% on average per year.
The Revenue is expected to decrease by -1.75% on average over the next years.
EPS Next Y38.18%
EPS Next 2Y-16.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.39%
Revenue Next 2Y-1.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BHR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BHR is valued cheaply inside the industry as 92.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.77

4.3 Compensation for Growth

A cheap valuation may be justified as BHR's earnings are expected to decrease with -16.17% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.17%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.35%, BHR is a good candidate for dividend investing.
BHR's Dividend Yield is a higher than the industry average which is at 16.05.
BHR's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 6.35%

5.2 History

The dividend of BHR decreases each year by -3.87%.
BHR has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BHR decreased in the last 3 years.
Dividend Growth(5Y)-3.87%
Div Incr Years1
Div Non Decr Years2

5.3 Sustainability

The earnings of BHR are negative and hence is the payout ratio. BHR will probably not be able to sustain this dividend level.
BHR's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-102.5%
EPS Next 2Y-16.17%
EPS Next 3YN/A

BRAEMAR HOTELS & RESORTS INC

NYSE:BHR (12/24/2024, 7:57:59 PM)

After market: 3.26 0 (0%)

3.26

+0.02 (+0.62%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-11 2024-11-11/dmh
Earnings (Next)N/A N/A
Inst Owners54.94%
Inst Owner Change-5.15%
Ins Owners1.29%
Ins Owner Change0%
Market Cap216.86M
Analysts48
Price Target3.32 (1.84%)
Short Float %1.89%
Short Ratio4.71
Dividend
Industry RankSector Rank
Dividend Yield 6.35%
Dividend Growth(5Y)-3.87%
DP-102.5%
Div Incr Years1
Div Non Decr Years2
Ex-Date12-31 2024-12-31 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.68%
Min EPS beat(2)-48.51%
Max EPS beat(2)95.87%
EPS beat(4)2
Avg EPS beat(4)38.87%
Min EPS beat(4)-50.11%
Max EPS beat(4)158.24%
EPS beat(8)3
Avg EPS beat(8)16.64%
EPS beat(12)6
Avg EPS beat(12)38.94%
EPS beat(16)9
Avg EPS beat(16)30.37%
Revenue beat(2)1
Avg Revenue beat(2)-2.33%
Min Revenue beat(2)-4.99%
Max Revenue beat(2)0.34%
Revenue beat(4)3
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-4.99%
Max Revenue beat(4)2.96%
Revenue beat(8)6
Avg Revenue beat(8)0.2%
Revenue beat(12)9
Avg Revenue beat(12)2.16%
Revenue beat(16)13
Avg Revenue beat(16)3.22%
PT rev (1m)-22%
PT rev (3m)-22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.45%
EPS NY rev (1m)34.86%
EPS NY rev (3m)34.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.5%
Revenue NY rev (1m)-0.96%
Revenue NY rev (3m)-0.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF 3.02
P/B 0.29
P/tB 0.3
EV/EBITDA 8.77
EPS(TTM)-0.77
EYN/A
EPS(NY)-1.57
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)1.08
OCFY33.14%
SpS11.01
BVpS11.09
TBVpS11.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.34%
ROE -6.91%
ROCE 2.13%
ROIC 1.77%
ROICexc 1.93%
ROICexgc 1.96%
OM 5.81%
PM (TTM) N/A
GM 69.13%
FCFM N/A
ROA(3y)-1.97%
ROA(5y)-2.68%
ROE(3y)-6.19%
ROE(5y)-10.17%
ROIC(3y)1.72%
ROIC(5y)N/A
ROICexc(3y)1.88%
ROICexc(5y)N/A
ROICexgc(3y)1.9%
ROICexgc(5y)N/A
ROCE(3y)2.08%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-3.21%
ROICexc growth 3YN/A
ROICexc growth 5Y-2.85%
OM growth 3YN/A
OM growth 5Y-6.77%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.06%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF N/A
Debt/EBITDA 8.43
Cap/Depr 75.84%
Cap/Sales 10.42%
Interest Coverage 0.42
Cash Conversion 50.17%
Profit Quality N/A
Current Ratio 1.17
Quick Ratio 1.15
Altman-Z 0.22
F-Score7
WACC7.56%
ROIC/WACC0.23
Cap/Depr(3y)219.37%
Cap/Depr(5y)209.36%
Cap/Sales(3y)26.94%
Cap/Sales(5y)28.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96%
EPS Next Y38.18%
EPS Next 2Y-16.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.11%
Revenue growth 3Y48.23%
Revenue growth 5Y11.38%
Sales Q2Q%-7.14%
Revenue Next Year-1.39%
Revenue Next 2Y-1.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-37.17%
EBIT growth 3YN/A
EBIT growth 5Y3.83%
EBIT Next Year148.72%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.34%
OCF growth 3YN/A
OCF growth 5Y3.68%